Literature DB >> 18677163

Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland.

Pedro Marques-Vidal1, Nicolas Rodondi, Murielle Bochud, Alain Pécoud, Daniel Hayoz, Fred Paccaud, Vincent Mooser, Gérard Waeber, Peter Vollenweider.   

Abstract

BACKGROUND: Prevention of cardiovascular disease (CVD) at the individual level should rely on the assessment of absolute risk using population-specific risk tables.
OBJECTIVE: To compare the predictive accuracy of the original and the calibrated SCORE functions regarding 10-year cardiovascular risk in Switzerland.
DESIGN: Cross-sectional, population-based study (5773 participants aged 35-74 years).
METHODS: The SCORE equation for low-risk countries was calibrated based on the Swiss CVD mortality rates and on the CVD risk factor levels from the study sample. The predicted number of CVD deaths after a 10-year period was computed from the original and the calibrated equations and from the observed cardiovascular mortality for 2003.
RESULTS: According to the original and calibrated functions, 16.3 and 15.8% of men and 8.2 and 8.9% of women, respectively, had a 10-year CVD risk > or =5%. Concordance correlation coefficient between the two functions was 0.951 for men and 0.948 for women, both P<0.001. Both risk functions adequately predicted the 10-year cumulative number of CVD deaths: in men, 71 (original) and 74 (calibrated) deaths for 73 deaths when using the CVD mortality rates; in women, 44 (original), 45 (calibrated) and 45 (CVD mortality rates), respectively. Compared to the original function, the calibrated function classified more women and fewer men at high-risk. Moreover, the calibrated function gave better risk estimates among participants aged over 65 years.
CONCLUSION: The original SCORE function adequately predicts CVD death in Switzerland, particularly for individuals aged less than 65 years. The calibrated function provides more reliable estimates for older individuals.

Entities:  

Mesh:

Year:  2008        PMID: 18677163     DOI: 10.1097/HJR.0b013e3282fb040f

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  17 in total

1.  The prevalence and management of cardiovascular risk factors in immigrant groups in Switzerland.

Authors:  Pedro Marques-Vidal; Peter Vollenweider; Gérard Waeber; Fred Paccaud
Journal:  Int J Public Health       Date:  2011-09-08       Impact factor: 3.380

Review 2.  Cardiovascular risk assessment: a global perspective.

Authors:  Dong Zhao; Jing Liu; Wuxiang Xie; Yue Qi
Journal:  Nat Rev Cardiol       Date:  2015-03-10       Impact factor: 32.419

Review 3.  Prediction models for risk classification in cardiovascular disease.

Authors:  Mario Petretta; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-03       Impact factor: 9.236

Review 4.  Assessment of cardiovascular risk.

Authors:  Marie Therese Cooney; Helen C Cooney; Alexandra Dudina; Ian M Graham
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

5.  The global risk approach should be better applied in French hypertensive patients: a comparison between simulation and observation studies.

Authors:  Ivanny Marchant; Patrice Nony; Michel Cucherat; Jean-Pierre Boissel; S Randall Thomas; Theodora Bejan-Angoulvant; Alexandra Laugerotte; Riad Kahoul; François Gueyffier
Journal:  PLoS One       Date:  2011-03-03       Impact factor: 3.240

6.  Regional differences in self-reported screening, prevalence and management of cardiovascular risk factors in Switzerland.

Authors:  Pedro Marques-Vidal; Fred Paccaud
Journal:  BMC Public Health       Date:  2012-03-28       Impact factor: 3.295

7.  Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran.

Authors:  Noushin Fahimfar; Akbar Fotouhi; Mohammad Ali Mansournia; Reza Malekzadeh; Nizal Sarrafzadegan; Fereidoun Azizi; Marjan Mansourian; Sadaf G Sepanlou; Mohammad Hassan Emamian; Farzad Hadaegh; Hamidreza Roohafza; Hassan Hashemi; Hossein Poustchi; Akram Pourshams; Tahereh Samavat; Maryam Sharafkhah; Mohammad Talaei; David Van Klaveren; Ewout W Steyerberg; Davood Khalili
Journal:  Int J Health Policy Manag       Date:  2022-02-01

8.  New insights into the management of hypertension and cardiovascular risk with Angiotensin receptor blockers: observational studies help us?

Authors:  Assen Goudev
Journal:  Open Cardiovasc Med J       Date:  2014-04-04

9.  Population specific and up to date cardiovascular risk charts can be efficiently obtained with record linkage of routine and observational data.

Authors:  David Faeh; Julia Braun; Kaspar Rufibach; Milo A Puhan; Pedro Marques-Vidal; Matthias Bopp
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

10.  Did Dumbo suffer a heart attack? independent association between earlobe crease and cardiovascular disease.

Authors:  Marta Aligisakis; Pedro Marques-Vidal; Idris Guessous; Peter Vollenweider
Journal:  BMC Cardiovasc Disord       Date:  2016-01-20       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.